HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanne Schnittger Selected Research

Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)

1/2020A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanne Schnittger Research Topics

Disease

48Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2014 - 03/2002
24Leukemia
01/2020 - 04/2002
16Neoplasms (Cancer)
02/2016 - 03/2002
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017 - 04/2005
9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2014 - 03/2002
6Acute Promyelocytic Leukemia
02/2018 - 01/2002
6Residual Neoplasm
03/2014 - 06/2006
6Chromosome Aberrations (Chromosome Abnormalities)
10/2010 - 04/2002
4Eosinophilia
12/2015 - 06/2006
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2011 - 08/2003
3Refractory Anemia
05/2013 - 06/2007
2Splenomegaly
09/2015 - 12/2014
2Systemic Mastocytosis
09/2015 - 10/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2014 - 07/2010
2Hematologic Neoplasms (Hematological Malignancy)
06/2013 - 03/2002
2Thrombocytosis (Thrombocythemia)
05/2013 - 07/2012
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2013 - 05/2012
1Disease Progression
10/2017
1Lymphadenopathy
09/2015
1Ascites
09/2015
1primary familial and congenital Polycythemia
01/2014
1Hypoxia (Hypoxemia)
01/2014
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2013
1Mast-Cell Leukemia (Leukemia, Mast Cell)
10/2013
1Anemia
07/2013
1Schinzel-Giedion syndrome
01/2013
1Primary Myelofibrosis (Myelosclerosis)
03/2011
1Thrombosis (Thrombus)
03/2011
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2011
1Glioma (Gliomas)
12/2010
1Philadelphia Chromosome
10/2010
1Multiple Myeloma
07/2010
1Myocardial Infarction
12/2008
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
12/2008
1Refractory Anemia with Excess of Blasts (RAEM)
06/2007

Drug/Important Bio-Agent (IBA)

9Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2015 - 02/2003
9Biological ProductsIBA
09/2014 - 10/2003
6Imatinib Mesylate (Gleevec)FDA Link
09/2014 - 05/2006
6Biomarkers (Surrogate Marker)IBA
08/2014 - 06/2011
6NucleophosminIBA
09/2009 - 12/2005
5Proteins (Proteins, Gene)FDA Link
12/2014 - 08/2003
5Messenger RNA (mRNA)IBA
09/2014 - 10/2006
4Hemoglobins (Hemoglobin)IBA
09/2015 - 03/2011
4Codon (Codons)IBA
03/2014 - 03/2006
4DNA (Deoxyribonucleic Acid)IBA
12/2013 - 03/2002
4OligonucleotidesIBA
07/2010 - 08/2003
3Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2018 - 08/2003
3Transcription Factors (Transcription Factor)IBA
02/2016 - 08/2005
3Janus Kinase 2IBA
12/2014 - 07/2012
3AntigensIBA
05/2013 - 11/2006
3Core Binding Factors (Core-Binding Factor)IBA
07/2010 - 04/2005
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2006 - 07/2003
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2018 - 06/2006
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
12/2015 - 06/2013
2CCAAT-Enhancer-Binding ProteinsIBA
10/2013 - 05/2012
2MicroRNAs (MicroRNA)IBA
10/2013 - 03/2008
2Phosphotransferases (Kinase)IBA
10/2010 - 02/2006
2promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
04/2005 - 01/2002
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2005 - 11/2002
2Monoclonal AntibodiesIBA
11/2004 - 01/2004
1dactolisibIBA
01/2020
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2020
1AnthracyclinesIBA
02/2018
1Azacitidine (5 Azacytidine)FDA Link
10/2017
1Dasatinib (BMS 354825)FDA Link
10/2017
1Tryptases (Tryptase)IBA
09/2015
1Janus Kinase InhibitorsIBA
12/2014
1Oxygen (Dioxygen)IBA
01/2014
12,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA
01/2014
1Tyrosine Kinase InhibitorsIBA
01/2014
1ErythropoietinFDA Link
01/2014
1Cyclin D1IBA
12/2013
1Protein Kinase CIBA
01/2013
1MDS1 and EVI1 Complex Locus ProteinIBA
12/2012
1Differentiation AntigensIBA
09/2012
1CD8 AntigensIBA
05/2012
1Core Binding Factor Alpha 2 SubunitIBA
12/2011
1Cyclin-Dependent Kinase Inhibitor p27IBA
06/2011
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2010
1EnzymesIBA
12/2010
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
07/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2010
1MDS 11IBA
10/2009
1Nuclear Proteins (Protein, Nuclear)IBA
05/2008
1NucleotidesIBA
03/2008
1Arginine (L-Arginine)FDA Link
07/2007
1Hydroxyurea (Hydrea)FDA LinkGeneric
05/2007

Therapy/Procedure

29Therapeutics
02/2018 - 03/2002
9Stem Cell Transplantation
03/2014 - 05/2006
6Drug Therapy (Chemotherapy)
02/2018 - 04/2002
3Hematopoietic Stem Cell Transplantation
02/2011 - 03/2010
2Transplantation
08/2011 - 08/2005
2Time-to-Treatment
10/2010 - 09/2010
2Induction Chemotherapy
01/2009 - 07/2006
2Radiotherapy
04/2002 - 03/2002
1Aftercare (After-Treatment)
02/2014
1Homologous Transplantation
04/2013
1Molecular Targeted Therapy
05/2008